Combination of CHK1 and CHK2 inhibitors exerts synergistic antitumor effects against neuroblastoma cells.

prexasertib (ACR-368) - Acrivon Therap

PV-1019 - Provid

http://www.ncbi.nlm.nih.gov/pubmed/42230907

Hidetoshi Hayashi; Hiroki Kakita; Hiromasa Aoki; Kazuya Izumi; Kohki Toriuchi; Mai Nagasaka; Mineyoshi Aoyama; Rina Kato; Satoru Takeshita; Yasumasa Yamada; Yasumichi Inoue

Jun 3, 2026